Report Publication Announcement • Feb 20, 2025
Report Publication Announcement
Open in ViewerOpens in native device viewer

Zoom conference call scheduled for March 6, 2025, 9:00 AM ET
Rehovot, February 20, 2025 - Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter of 2024, on Thursday, March 6, 2025.
Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time).
To join the conference, please register in advance: https://us06web.zoom.us/webinar/register/WN\_1cToyoipTfW8X0xtgEqPfw
The entire conference will be available online on the company's website a few days after.
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.
Evogene established three unique tech-engines - MicroBoost AI, ChemPass AI and GeneRator AI. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

For more information, please visit: www.evogene.com.
Tel: +972-8-9311901
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.